Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Groen

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
British Journal of Cancer|March 10, 1999
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecinR S de Jong, N H Mulder, D R Uges, et al.
British Journal of Cancer|February 12, 1998
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patientsM Bakker, J P Droz, A R Hanauske, et al.
Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.
British Journal of Cancer|August 17, 2000
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumoursR Paridaens, D R Uges, N Barbet, et al.
Nature Genetics|February 7, 2017
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosisBrian D Hobbs, Kim de Jong, Maxime Lamontagne, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
British Journal of Cancer|March 10, 1999
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecinR S de Jong, N H Mulder, D R Uges, et al.
British Journal of Cancer|February 12, 1998
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patientsM Bakker, J P Droz, A R Hanauske, et al.
Bulletin Du Cancer|March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]T Le Chevalier, M Gottfried, U Gatzemeier, et al.
British Journal of Cancer|August 17, 2000
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumoursR Paridaens, D R Uges, N Barbet, et al.
Nature Genetics|February 7, 2017
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosisBrian D Hobbs, Kim de Jong, Maxime Lamontagne, et al.
Pageof 8